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The Cycles of American Drug Policy
by David T. Courtwright—forthcoming in The American Historian (August 2015)

The historian Charles Beard once said that historical narratives spring from one of three
incompatible premises: Either history is chaos that defies interpretation, or it is cyclical, or it moves
in a line in some direction. Beard judged all written history “an act of faith” in which historians had
to choose one of these frames for the story they wanted to tell.1
Historians of American drug policy have favored Beard’s cyclical approach, describing
reform traditions that moved into and out of favor. Progressivism emerged first, then Liberalism,
then the Drug War, and then a movement I’ll call End the Drug War. Because ideas and generations
do not enter and exit history on cue, there was some overlap among the reform traditions. Even so,
each had distinctive periods of intensifying propaganda and legislative activity. Progressivism’s
crucial phase ran from 1906 to 1924; Liberalism’s from 1962 to 1972; the Drug War’s from 1971 to
1973 and again from 1977 to 1996; and End the Drug War’s from 1996 to the present.
Each of these reform traditions included “soft” and “hard” camps. For example, progressive
reformers divided over the question of whether the nonmedical use of alcohol and narcotic drugs
should be regulated or prohibited outright. While the changes in reform fashion had many causes,
the most obvious was the triumph of the hard-policy advocates, who invariably provoked a reaction
that sent opinion in the other direction. This cyclical pattern repeated itself through the twentieth
century, setting in motion a policy pendulum that seems likely to go on swinging, even as the drug
war finally winds down.

1

Progressivism
The first reform tradition, Progressivism, created the modern system of drug regulation and
selective prohibition. Victorian reformers on both sides of the Atlantic had long worried that
commercialized vices—particularly the liquor trade, gambling, prostitution, pornography, narcotics
trafficking, and tobacco smoking—were spreading, as indeed they were. Industrialization,
technological refinements, and improved transportation had made spirits, narcotics, and cigarettes
cheaper, more potent, and more widely available. A transnational coalition of reformers attacked this
commerce at home and abroad, including in colonies that derived much of their revenue from trade
in opium and gin.
In America, the reformers crafted a variety of local ordinances, state laws, and federal
statutes, the most important of which were enacted during the Progressive Era. But there was a
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catch. While all progressives agreed that drug commerce should be reined in, they did not necessarily
agree on the means, whether through regulation or strict prohibition of nonmedical use. Nor did
they always agree on which psychoactive substances should be banned.
Bishop Charles Henry Brent, who served as a missionary bishop in the Philippines and
witnessed the effects of the opium trade there, epitomized the soft progressive approach. Brent
chaired the international opium conferences in 1909 and 1911–1912 and helped to create the
modern treaty system to limit narcotic production to estimated medical needs. More than any other
person, he inspired and shaped international narcotic control. But Brent, a liberal Episcopalian,
parted company with his evangelical brethren on similar measures for alcohol control. Brent, in fact,
opposed the Volstead Act of 1919, which prohibited beverage alcohol for other than home, medical,
and sacramental purposes. Fellow progressive Woodrow Wilson likewise opposed the law, but
Congress overrode the bedridden president’s shakily signed veto.
The majority of Americans thought like Brent and Wilson and agreed with the soft
progressive approach. But an unusual combination of circumstances—World War I, resurgent
nativism, alternative revenue from the new income tax, malapportionment favoring “dry” rural
voters, and creative single-issue politics—enabled hard progressives to secure ratification of the
Eighteenth Amendment and veto-proof passage of the Volstead Act. In the same year, 1919, hard
progressives celebrated a 5–4 Supreme Court ruling that upheld the Treasury Department’s antimaintenance interpretation of the Harrison Narcotic Act of 1914. (A pro-maintenance decision
would have allowed legal drugs for addicts, regardless of their health or the origin of their
condition.) Between 1895 and 1927, hard progressives even managed to persuade fifteen states to
ban the sale, and sometimes the manufacture and use, of cigarettes. In 1924, Congress also forbade
the manufacture of heroin.
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Yet cracks soon began appearing in hard progressivism’s façade. Perhaps most important
was National Repeal in 1933, which commenced a steady decline in the number of dry states,
counties, and municipalities. Cigarette manufacturers overcame all legal and social obstacles to turn
their product into the great modern pacifier. And new habit-forming drugs, barbiturates and
amphetamines, caught on in medical and nonmedical circles.
However, hard progressives still held sway at the Federal Bureau of Narcotics. The BON, as
it was known, monitored supplies of opiates and cocaine, prosecuted traffickers, forbade
nonmedical maintenance, isolated and stigmatized addicts, and urged states to adopt stricter uniform
drug laws. Harry Anslinger, head of the BON from 1930 to 1962, also had an impact on federal
legislation. In 1937 he urged Congress to make marijuana an illicit drug, which it did through the
Marijuana Tax Act. In the 1950s Anslinger lobbied for mandatory minimum sentences, which
Congress authorized in the 1951 Boggs Act and the 1956 Narcotic Control Act. State legislatures
tagged along, enacting “Little Boggs Laws.”

Liberalism
In the 1940s and 1950s a handful of liberal critics began challenging Anslinger’s hard-line
tactics and, more broadly, the double standard of American drug policy. The punitive demonization
of narcotics, cocaine, and marijuana, combined with the lax regulation of licit drugs like alcohol,
tobacco, and barbiturates, struck them as unwise and hypocritical. The authors of the 1944
LaGuardia Committee report found that marijuana smoking was less dangerous than supposed, and
all but nonexistent among New York City school children. They were nonetheless shocked by
students’ widespread use of cigarettes, easily purchased from candy stores and street vendors.
Liberals wanted a policy that was longer on reason and shorter on zeal. They denied that
illicit drug use necessarily produced aberrant behavior, or that it always led to addiction. When it did,
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addicts should be treated and rehabilitated, not ostracized or forced into the black market.
Expensive drugs caused addicts to commit crimes. Adulterated drugs caused them to drop dead.
Maintenance had been tried successfully in Great Britain. Why not try it in America, at least on an
experimental basis?
In 1958 the American Bar Association and the American Medical Association released an
expert report that tactfully questioned the police approach and the denial of maintenance trials. The
criticism enraged Anslinger, who accused the authors of coddling addicts and comforting
communists. But by now such bullying did more harm than good. It provoked long-time critics such
as Lawrence Kolb, the dean of the country’s addiction researchers and the first medical
superintendent of the federal narcotic hospital in Lexington, Kentucky, which opened in 1935. Kolb
thought his patients’ addictions were symptoms of mental disease, not perversions of character.
They needed to be “supervised rather than repressed.” He challenged hard-progressive
propagandists, denounced long prison sentences, and, in 1962, issued a durable manifesto: “This
country suffers less from the disease than from the misguided frenzy of suppressing it.”2
Just as there were hard and soft progressives, there were hard and soft liberals. What
separated soft liberals like Kolb from hard liberals were two issues around maintenance—who
should get it, and for how long? The questions became pressing during the 1960s, when the
physicians Vincent Dole and Marie Nyswander demonstrated that methadone, a long-acting
synthetic narcotic that addicts took orally, was a highly effective maintenance drug. Methadone
programs expanded rapidly in the wake of a national heroin-addiction epidemic in the late 1960s and
early 1970s. Like other hard liberals, Dole and Nyswander questioned whether treatment should
necessarily aim at abstinence. They believed that indefinite, high-dose methadone maintenance was
the most realistic goal for many of their patients. Health and behavior were what mattered, not the
presence or absence of opiates.
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Hard liberals also tended to support marijuana decriminalization and tighter regulation of
other drugs, including sedatives, stimulants, alcohol, and tobacco—the gist of Edward M. Brecher’s
1972 bestseller, Licit and Illicit Drugs. The early 1970s was a time of ferment in drug policy and
treatment, a moment when the old paradigm of double-standard progressivism seemed to be giving
way to the more rational paradigm of public-health liberalism.

The War on Drugs
Then politics got in the way, which is why many people recall the early 1970s as both the
golden age of medicalization and the beginning of the drug war. They are not wrong to do so. The
new president, Richard Nixon, took a unique approach to drugs after he assumed office in 1969. An
unusually protean politician, Nixon was a pragmatist who stitched together domestic policies out of
disparate elements that suited his immediate political purposes. His eclecticism was on full display in
his drug policy, which drew on all of the previous reform traditions.
For most drugs, Nixon favored expert-determined scheduling and prescription regulations—
that is, soft progressivism. Liberals soft and hard supported portions of the 1970 Controlled
Substances Act, which systematized drug scheduling, provided new money for public health
approaches, and eliminated most mandatory minimum sentences, including those for cannabis
possession. Nixon launched the Special Action Office for Drug Abuse Prevention and the National
Institute on Drug Abuse, giving them unprecedented resources for treatment and research. And he
listened to his advisers and backed methadone.
Yet Nixon also had a streak of hard progressivism. He believed that illicit drug use
threatened the nation’s future. During his 1962 California gubernatorial campaign, he had called for
the death penalty for drug traffickers with multiple convictions. And, in 1971, Nixon officially
launched his own drug war, which featured anti-drug rhetoric and photo ops. The following year,
6

Nixon’s drug war took a harder turn with the rejection of the liberal Shafer Commission’s report on
marijuana and the establishment of the Office of Drug Abuse Law Enforcement, which coordinated
sweeps against street dealers. In January 1973, after New York Governor Nelson Rockefeller
proposed draconian drug laws, Nixon expressed frank admiration, captured on the White House
tapes. In March 1973 Nixon attempted to follow suit, proposing that Congress enact minimum fiveyear terms for convicted heroin traffickers and life without parole for traffickers who had prior drug
felonies.
Nixon’s premature gambit to nationalize the Rockefeller Drug Laws got lost in the
Watergate crisis. But the drug war toward which Nixon was veering sprang back to life in the late
1970s and early 1980s. The national mood was changing, as both economic and moral conservatives
attacked the waning liberal political consensus. New Right activists accused liberals of fostering
dependency and permissiveness, as demonstrated by the ongoing drug crisis. Heroin may have
peaked, but cocaine and cannabis were more fashionable than ever. By 1979 two-thirds of highschool seniors had tried an illicit drug, most often marijuana.
The antidrug parents’ groups that began forming in 1977 wanted marijuana restigmatized,
zero tolerance, more resources for law enforcement, youth prevention programs, and tough-love
treatment, including therapeutic communities geared toward abstinence. For these activists and their
allies in the newly elected Reagan administration, methadone was worse than irrelevant. Let kids get
high, work their way up to heroin, and then put them on methadone? That was the sort of twisted
thinking you would expect from the “New York” psychiatric crowd.3
If First Lady Nancy Reagan provided the public face for the drug war’s moralizing and
budget-shifting phase, President George H. W. Bush provided the signature moment for its hard,
carceral phase. On September 5, 1989, when he displayed to a national television audience a bag of
crack allegedly seized near the White House, Congress had already passed two antidrug laws that
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were bigger and harsher than anything from the 1950s. But Bush called for more punitive legislation.
So did Senator Joe Biden, who delivered the Democrats’ televised response. “Not tough enough,”
Biden said. He demanded more police, prosecutors, judges, and cells to lock up drug thugs “for a
long time.” Drug policy had become a partisan bidding game, which was why President Bill Clinton
had little room for maneuver during his 1993–2001 administration.4

End the Drug War
Even so, the last of the four reform movements, End the Drug War, gained traction during
the 1990s. Mass incarceration had decimated minority communities, yet produced no decline in the
purity or availability of drugs. What Kolb had said in 1962, about the cure being worse than the
disease, resonated in the age of AIDS. Harm-reduction researchers such as Don Des Jarlais, an
international authority on HIV infection, supported needle and syringe programs—“NSPs”—to
provide sterile injection equipment to users. Like liberals, harm-reductionists wanted addicts in
treatment rather than in prison. Treatment included medically assisted recovery with methadone or,
later, buprenorphine. Most harm-reductionists also favored medical marijuana, in part because they
recognized its use in alleviating the symptoms of AIDS and other chronic diseases.
Today, harm reduction is in the ascendancy. Since 1996 twenty-three states and the District
of Columbia have enacted medical marijuana laws, which the U.S. Justice Department has declined
to trump with the Schedule I status of cannabis. Notoriously strict sentences for crack-cocaine
convictions have been amended. Before his departure, Attorney General Eric Holder announced a
review of the federal asset-forfeiture program and new clemency opportunities for drug offenders,
efforts supported by conservatives worried about government overreach and rising prison costs.
Some reformers have demanded more sweeping changes, including recreational cannabis
purchases by adults (so far enacted by four states), heroin maintenance clinics, and an end to all
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Schedule I blanket prohibitions. At its limit, End the Drug War becomes libertarianism à la Milton
Friedman, one of the earliest and most consistent critics of drug prohibition. Given the waning of
the larger culture war that framed the drug war of the 1980s and 1990s and given the ongoing
secular and libertarian drift of American culture, particularly among the young, it seems likely that at
least some states will venture further down the legalization path.
This does not mean, however, that Beard’s cyclical pattern is destined to turn into a line. If
(and where) harm reduction evolves into drug libertarianism, it will produce another political
reaction. Legalization undercuts black markets, but not gray markets. Drug diversion and youthful
experimentation will remain sensitive political issues, just as overdoses and addiction will remain
serious public health concerns. A good example is the aftermath of liberalized opioid prescribing for
chronic pain patients, a movement promoted by pharmaceutical companies that bore commercial
fruit in the mid-1990s. Oxycodone and hydrocodone sales rose sharply, but so did overdose deaths
and addiction.5 The result was state regulatory crackdowns and the rise of neo-progressive advocacy
groups such as Physicians for Responsible Opioid Prescribing. To the extent that the legalization of
marijuana (or any other drug) produces more addiction and more health and developmental
problems, it will generate a similar pushback.
Given what we now know about the common neural pathways of substance and behavioral
addictions, it is virtually certain that neo-progressives will aim at more than drugs. Among their likely
targets are foods and beverages loaded with fat, salt, and sugar—the last the culprit in New York
City Mayor Michael Bloomberg’s abortive (or perhaps premature) 2012–2013 campaign against large
soda drinks. Neo-progressives have also raised alarms about electronic gambling machines, addictive
digital pastimes, and vaping. The basic historical problem, that commercial interests can hook us
with products that are bad for us, has not gone away. In fact, it has gotten much worse. Therefore it
is hard to imagine a future in which the regulatory impulse will simply go away. It is possible to
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imagine a future in which we do not let the regulatory impulse run away. But that will require reining
in two of the forces, political advantage and ideological messianism, that have destabilized drug
policy for more than a century.
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